Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer
Ontology highlight
ABSTRACT: This trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that adaptive radiotherapy for muscle-invasive bladder cancer will translate into a decreased rate of acute (assessed weekly during chemo-radiotherapy) grade 3 or greater gastrointestinal/genitourinary toxicity compared with the historically reported rate for non-adaptive radiation therapy. The Common Terminology Criteria for Adverse Events (CTCAE) version 5 assessment tool will be utilized.
DISEASE(S): Carcinoma, Transitional Cell,Muscle Invasive Bladder Urothelial Carcinoma,Urinary Bladder Neoplasms
PROVIDER: 6198 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA